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Many attempts to reduce restenosis after angioplasty by sys-
temic administration of a variety of agents have not succeeded
(1). Recently, the idea of local therapy of diseased segments
has gained attention (2,3) . The appeal is based on the ability to
achieve enormous concentrations of drugs at or near the
injured segment, the possibility of reduced toxicity by local
application and conservation of expensive, highly specific
molecular and genetic drugs (2) . In a very short time, percu-
taneous devices have appeared that are designated porous,
microporous, double-balloon, Hydrogcl coated, iontophoretic
and even microinjector, with retractable needles (3-5) . Drug
or gene delivery can utilize liposomes, microspheres, electro-
porated platelets or polymer matrix slabs (2,3,6,7). Clearly, the
challenge of validating a device-drug combination is more
complex than that of a device alone .
With few exceptions, this outpouring of ingenuity has not
been matched by systematic experimental study . Questions of
infusion pressure needed and volume and toxicity of solutions
delivered are a few among many variables that need to be
addressed (2) . Add to that the lack of clearly acceptable animal
models (8) and the lack of a clearly effective agent (1,2) and it
is easy to see how the situation is becoming chaotic .
Problems in experimental design . My goal is 1) to address
certain problems that have already appeared, and 2) to venture
a suggestion as to how the situation might be improved . Lack
of a good animal model for restenosis has led some to suggest
that several animal models be used to validate a device-drug
combination for safety and effectiveness and that the pig
coronary artery he included because of its structural similarity
to the human artery (8,9) . The lack of an effective agent has
been frustrating but may be coming to an end . Antisense
oligonucleotides of the c-myb and c-myc types have been
shown to suppress cell proliferation in rat, rabbit and swine
arteries, with resulting enlargement of the artery lumen com-
pared with controls (10,11).
Perhaps the greatest concern about the present situation
with its numerous devices and drugs used under a variety of
conditions is that an effective agent or device will be deemed
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ineffective, when under "proper" use it would solve the
problems of restenosis. This might occur, for example, if active
drug were not delivered properly or for adequate timing and
duration (12) or if the device used produced more damage
than the effective agent could overcome . Even small variations
in porous catheter design, such as hole size and number, can
greatly influence liquid delivery (2) .
Damage from local therapy. It is clear that device-drug
combinations can damage the artery wall . An attempt to
combine high pressure angioplasty with simultaneous local
liquid infusion into arterial segments has met with disastrous
perforations (13) . Other studies have suggested that even when
used alone to deliver fluid to normal swine arteries, one porous
device caused arterial damage at 10-bars syringe pressure, less
at 5 bars and virtually none at 2 .5 bars (14) . Others have shown
no significant damage in dozens of arteries at 4 to 5 bars of
pressure (11,15) . Even when proliferating cell nuclear antigen
(PCNA) antibodies were used to assess subtle changes in cell
proliferation, no increase could be seen from infusion alone
through the porous catheter (Zalewsk ; A, personal communi-
cation, June 1994). When direct wall pressure by means of the
two-balloon catheter was measured in one model for damage
effects, 350 mm fig was damaging, 150 mm fig was not (16) .1
have attempted to summarize many of these seemingly con-
flicting results in Table 1 for one type of porous catheter (17)
and one double-balloon catheter (18) for which equivalent
direct wall pressures are known (17) . In all cases the infusion
time was <I min, and the volume infused was <3 ml, usually
2 ml. What seems striking is that for normal arteries, accept-
able pressures seem to be related to wall thickness of the
muscular artery, which in turn depends on the species being
studied. Thinner walls require lower infusion pressures . (All
arterial wall thicknesses 119,201 have been corrected for dis-
tention to physiologic pressure and for tissue shrinkage due to
processing 1211). It is interesting, for example, that if only 2
bars of syringe infusion pressure is used for the dog peripheral
artery, marker dye penetrates only one-third through the
medial thickness (22), whereas 4 bars penetrates the entire
wall . Similarly, if pore size is reduced to minimize pressure
effects, instead of full-thickness penetration, only 15% of the
wall area is stained (23) . Seemingly disparate results can be
made consistent when variables are controlled, as shown in
Table 1 .
Large molecules and the normal artery. Nowhere has the
concern about possible damage been greater than among those
attempting to deliver viral vectors, gene products or liposomes
to the arterial wall
(2,16) . Cellular damage produced by
?device-infusion perturbations can blur demonstration of ge-
~ietic or molecular effects of the infusate . Indeed, efficiency of
gene manipulation has been very low when calculated on the
basis of percent of medial cells showing the desired gene effect
(2) .
"Anatomic barriers" in the normal vessel wall have been
incriminated in the limited entrance of liposomes or viral
vectors at nondamaging pressures (100 to 400 mm fig direct
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Table 1 . Relation of Wall Penetration to Wall Pressure in Muscular
Arteries of Different Species
'Porous balloon catheter (17) . tDoublc •h allcon catheter (I8).
pressure) . At higher pressures (5(10 mnm Hg direct pressure or
5-bar syringe pressure), penetration is seen . but wall damage is
considerable (24) . These anatomic harriers most likely consist
of tht: internal elastic lamina and other fibroclastic structures,
which are known to impede transmural passage of circulating
large molecules through normal arteries (25) .
Treatment of diseased arteries . Are concerns about subtle
wall damage to and anatomic barriers of normal arteries
relevant to the clinical goals of local therapy? Let us remember
what the clinical situation is. Angioplasty results in enormous
damage to the arterial wall: tears and dissections extend
through the media and adventitia (1) . Hemorrhage and necro-
sis arc seen. Other vascular diseases, such as vasculitis or
atheroslcerosis, which might be the object of genetic therapy,
characterically destroy wall integrity, effacing the usual tight
organization of normal vascular tissue .
The intimal atheroscl'rotic plaque subjected to angioplasty
is often 'tundreds of microns thick, often thicker than the
underlying media (19). Indeed, it has been shown that even
without tears and dissections, plaque tissue is more permeable
to circulating materials than the normal arterial wall (26) .
Does local therapy add to damage? A fundamental ques-
tion that rclat.s to the safety and efficacy of a device-infusion
system is, Does it increase the damage or wall response, or
both, beyond that caused by the initial simple angioplasty or
disease process? If it does not, we can then examine a drug
being tested for eventual benefit on the repair process in the
artery wall . In all cases, the arterial wall is the point of focus for
safety and effectiveness.
In the report by Plante et al . (27) in this issue of the Journal,
infusion of fluid through a porous catheter before angioplasty
of rabbit iliac artery was compared with angioplasty
alone.
Fluid infusion caused no further stimulation of thymidinc
incorporation at 4 days or development of ncointima at 30 days
after injury compared with angioplasty alone . This reassuring
finding of no added cell proliferation from infusion and
angioplasty compared with standard angioplasty alone has also
been found in the rabbit hyperplastic iliac artery model
(Rosenberg R, personal communication, June 1994) .
It would seem worthwhile, when viral vectors and gene-
bearing liposomes are infused to alter cellular behavior, to use
diseased animal models that allow ready penetration of these
large carriers, a situation more akin to clinical circumstances
.
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Previous disruption of plaque architecture (and "harriers") by
mechanical means, simple induction of intimal plaques or
production of medial diseases before introduction of the
modifying agent seems a more appropriate test of eventual
safety and efficacy under clinical conditions .
Unanswered questions . There is much that we do not
know. It may not be necessary to penetrate the entire wall
thickness; conversely, it would seem undesirable to force fluid
beyond the adventitia and into the myocardium or other
surrounding tissue . If the goal were to influence surface events,
such as platelet adherence or thrombosis (28), relatively shal-
low deposition of active agent in the artery wall may he
sufficient . However, if a sizeable depot of active drug were
desired to mimic adventitial release over a longer period (7),
full penetration of the entire wall night he needed .
Conclusions. 1 have attempted to emphasize the impor-
tance of tailoring drug-device conditions to the vascular tissue
being manipulated. Artery size. thic'ness, disease state and
previous manipulation will all affect the performance of a given
technique of local delivery .
By systematic attention to these factors, more coherent
interpretation of improvement or deterioration of the under-
lying vascular disease may he possible . Seemingly conflicting
results can be accommodated in a unifying concept if these
details are considered beforehand . A device or other specific
local therapy can initially he assessed for general procedural
details under idealized conditions using normal vessels . How-
ever, safety and utility will ultimately best he considered in
models that more closely simulate the disease being treated .
including previous tissue manipulation where that is part of the
clinical sequence. In this way, potential harm from the inter-
vention will neither he exagerrated nor underestimated . We
can thereby increase the likelihood that experimental success
will ultimately he reflected in clinical success . With so many
new devices at an early stage of development, and with so many
potential therapeutic agents, we can best assess the ultimate
value of local therapy if we "keep our eyes on the wall ."
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